ENEBAKK BIOPRODUKTER AS
7113 HUSBYSJØEN
Return on Equity
58,74Â %
Current Ratio
7,83
Debt-to-Equity Ratio
6,45
| Key figures (NOK) | 2022 | |
|---|---|---|
| Revenue | 1Â 614Â 000 | |
| Net Income | 84Â 000 | |
| Total Assets | 1Â 204Â 000 | |
| Total Equity | 143Â 000 |
| Income (NOK) | 2022 | |
|---|---|---|
| Revenue | 1Â 614Â 000 | |
| Expenditure | 1Â 464Â 000 | |
| Operating Profit | 150Â 000 | |
| Financial Income | 0 | |
| Financial Costs | 60Â 000 | |
| Financial Balance | −60 000 | |
| Earnings Before Tax | 90Â 000 | |
| Tax | 6Â 000 | |
| Net Income | 84Â 000 |
| Balance (NOK) | 2022 | |
|---|---|---|
| Total Fixed Assets | 115Â 000 | |
| Total Current Assets | 1Â 089Â 000 | |
| Total Assets | 1Â 204Â 000 | |
| Total Retained Equity | −89 000 | |
| Total Equity | 143Â 000 | |
| Total Long-Term Debt | 922Â 000 | |
| Total Current Debt | 139Â 000 | |
| Total Equity and Debt | 1Â 204Â 000 |
| Cash flow (NOK) | 2022 | |
|---|---|---|
| Sales Income | 1Â 614Â 000 | |
| Other Income | 0 | |
| Revenue | 1Â 614Â 000 | |
| Cost of Goods Sold | 1Â 258Â 000 | |
| Salary Costs | 0 | |
| Depreciation | 57Â 000 | |
| Impairment | 0 | |
| Expenditure | 1Â 464Â 000 | |
| Operating Profit | 150Â 000 | |
| Financial Income | 0 | |
| Financial Costs | 60Â 000 | |
| Financial Balance | −60 000 | |
| Dividends | 0 | |
| Net Income | 84Â 000 |
| Balance details (NOK) | 2022 | |
|---|---|---|
| Goodwill | 0 | |
| Total Intangible Assets | 0 | |
| Real Eastate | 0 | |
| Machinery and Plant Facilities | 106Â 000 | |
| Fixtures | 9Â 000 | |
| Total Tangible Assets | 115Â 000 | |
| Total Fiancial Fixed Assets | 0 | |
| Total Fixed Assets | 115Â 000 | |
| Stock | 70Â 000 | |
| Total Investments | 0 | |
| Cash, Bank | 340Â 000 | |
| Total Current Assets | 1Â 089Â 000 | |
| Total Assets | 1Â 204Â 000 | |
| Total Equity | 143Â 000 | |
| Short-Term Group Debt | 0 | |
| Total Long-Term Debt | 922Â 000 | |
| Creditors | 47Â 000 | |
| Unpaid Taxes | 77Â 000 | |
| Dividends | 0 | |
| Other Current Debt | 8Â 000 | |
| Total Current Debt | 139Â 000 | |
| Total Equity and Debt | 1Â 204Â 000 |
| Financial indicators | 2022 | |
|---|---|---|
| Return on Equity | 58,74Â % | |
| Debt-to-Equity Ratio | 6,45 | |
| Operating Profit Margin | 9,29Â % | |
| Current Ratio | 7,83 | |
| Quick Ratio | 15,78 | |
| Equity Ratio | 0,12 | |
| Gross Profit Margin | 22,06Â % |
Rotate your device to see the full table